Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease

Clinical Endocrinology

Volumn 62, Issue 2, 2005, Pages 242-249

  Díez, Juan J ^a   Iglesias, Pedro ^b   Fernández Reyes, María J ^b   Aguilera, Abelardo ^d   Bajo, María A ^c   Alvarez Fidalgo, Pilar ^c   Codoceo, Rosa ^c   Selgas, Rafael ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL GENERAL DE SEGOVIA   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; RESISTIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HEART DISEASE; HEMODIALYSIS; HOMEOSTASIS; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TREATMENT OUTCOME; UREMIA;

ADIPONECTIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; HORMONES, ECTOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; RESISTIN;

EID: 13444311058     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02207.x     Document Type: Article

References (31)

1. Kershaw, E.E. & Flier, J.S. (2004) Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism, 89, 2548-2556.
2. Mantzoros, C.S. (1999) The role of leptin in human obesity and disease: a review of current evidence. Annals of Internal Medicine, 130, 671-680.
3. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y. & Matsubara, K. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochemical and Biophysical Research Communications, 221, 286-289.
4. Díez, J.J. & Iglesias, P. (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology, 148, 293-300.
5. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S. & Lazar, M.A. (2001) The hormone resistin links obesity to diabetes. Nature, 409, 307-312.
6. Heimbürger, O., Lonnqvist, F., Danielsson, A., Nordenstrom, J. & Stenvinkel, P. (1997) Serum immunoreactive leptin concentrations and its relation to the body fat content in chronic renal failure. Journal of the American Society of Nephrology, 8, 1423-1430.
7. Merabet, E., Dagogo Jack, S., Coyne, D.W., Klein, S., Santiago, J.V., Hmiel, S.P. & Landt, M. (1997) Increased plasma leptin concentration in end-stage renal disease. Journal of Clinical Endocrinology and Metabolism, 82, 847-850.
8. Nordfors, L, Lönnqvist, F., Heimbürger, O., Danielsson, A., Schalling, M. & Stenvinkel, P. (1998) Low leptin gene expression and hyper-leptinemia in chronic renal failure. Kidney International, 54, 1267-1275.
9. Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F.A., Cutrupi, S., Parlongo, S., Malatino, L.S., Bonanno, G., Seminara, G., Rapisarda, F., Fatuzzo, P., Buemi, M., Nicocia, G., Tanaka, S., Ouchi, N., Kihara, S., Funahashi, T. & Matsuzawa, Y. (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology, 13, 134-141.
10. Stenvinkel, P., Marchlewska, A., Pecoits-Filho, R., Heimburger, O., Zhang, Z., Hoff, C, Holmes, C., Axelsson, J., Arvidsson, S., Schalling, M., Barany, P., Lindholm, B. & Nordfors, L. (2004) Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney International, 65, 274-281.
11. Foley, R.N., Parfrey, P.S. & Sarnak, M.J. (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. American Journal of Kidney Diseases, 32, S112-S119.
12. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
13. Pérez Fontán, M., Rodríguez-Carmona, A., Cordido, F. & García-Buela, J. (1999) Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: a comparative analysis. American Journal of Kidney Diseases, 34, 824-831.
14. Rodríguez-Carmona, A., Pérez Fontán, M., Cordido, F., García Falcon, T. & García-Buela, J. (2000) Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. Nephron, 86, 274-280.
15. Kagan, A., Haran, N., Leschinsky, L., Shuali, N. & Rapoport, J. (1999) Leptin in CAPD patients: serum concentrations and peritoneal loss. Nephrology, Dialysis and Transplantation, 14, 400-405.
16. Aguilera, A., Codoceo, R., Bajo, M.A., Iglesias, P., Díez, J.J., Barril, G., Cigarrán, S., Alvarez, V., Celadilla, O., Fernández-Perpén, A., Montera, A. & Seigas, R. (2004) Eating behavior disorders in uremia: a question of balance in appetite regulation. Seminars in Dialysis, 17, 44-52.
17. Huang, J.W., Yen, C.J., Chiang, H.W., Hung, K.Y., Tsai, T.J. & Wu, K.D. (2004) Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. American Journal of Kidney Diseases, 43, 1047-1055.
18. Zoccali, C., Mallamaci, F., Panuccio, V., Tripepi, G., Cutrupi, S., Parlongo, S., Catalano, F., Tanaka, S., Ouchi, N., Kihara, S., Funahashi, T. & Matsuzawa, Y. (2003) Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney International, 63, S98-S102.
19. Kielstein, J.T., Becker, B., Graf, S., Brabant, G., Haller, H. & Fliser, D. (2003) Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. American Journal of Kidney Diseases, 42, 62-66.
20. Vettor, R., De Pergola, G., Pagano, C., Englaro, P., Laudadio, E., Giorgino, F., Blum, W., Giorgino, R. & Federspil, G. (1997) Gender differences in serum leptin in obese people: relationship with testosterone, body fat distribution and insulin sensitivity. European Journal of Clinical Investigation, 27, 1016-1024.
21. Matsubara, M., Maruoka, S. & Katayose, S. (2002) Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology, 147, 173-180.
22. Choi, K.M., Lee, J., Lee, K.W., Seo, J.A., Oh, J.H., Kim, S.G., Kim, N.H., Choi, D.S. & Baik, S.H. (2004) The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors. European Journal of Endocrinology, 150, 715-718.
23. Malyszko, J., Wolczynski, S., Malyszko, J. & Mysliwiec, M. (2002) Leptin correlates with some hemostatic parameters in CAPD patients. Nephron, 92, 721-724.
24. Rea, R. & Donnelly, R. (2004) Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes, Obesity and Metabolism, 6, 163-170.
25. Furuhashi, M., Ura, N., Higashiura, K., Murakami, H. & Shimamoto, K. (2003) Circulating resistin levels in essential hypertension. Clinical Endocrinology, 59, 507-510.
26. Ducloux, D., Bresson-Vautrin, C, Kribs, M., Abdelfatah, A. & Chalopin, JM. (2002) C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney International, 62, 1417-1422.
27. Engeli, S., Feldpausch, M., Gorzelniak, K., Hartwig, F., Heintze, U., Janke, J., Mohlig, M., Pfeiffer, A.F., Luft, F.C. & Sharma, A.M. (2003) Association between adiponectin and mediators of inflammation in obese women. Diabetes, 52, 942-947.
28. Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Nishida, M., Kumada, M., Okamoto, Y., Ohashi, K., Nagaretani, H., Kishida, K., Nishizawa, H., Maeda, N., Kobayashi, H., Hiraoka, H. & Matsuzawa, Y. (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation, 107, 671-674.
29. Schulze, M.B., Rimm, E.B., Shai, I., Rifai, N. & Hu, F.B. (2004) Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care, 27, 1680-1687.
30. Zoccali, C., Mallamaci, F. & Tripepi, G. (2003) Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney International, 63, S65-S68.
31. Marchlewska, A., Stenvinkel, P., Lindholm, B., Danielsson, A., Pecoits-Filho, R., Lönnqvist, F., Schalling, M., Heimbürger, O. & Nordfors, L. (2004) Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney International, 66, 46-50.